MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4292/wjgpt.v16.i4.111977

Медицинская библиотека · World journal of gastrointestinal pharmacology and therapeutics · 2025

L-arginine-induced chronic pancreatitis in mice: Evaluating effects of pirfenidone and simvastatin.

Mehta Rajiv, Patel Archi, Vyas Bhavin, Desai Bhargavi, Adhvaryu Dhvani, Sojitra Prakash, Bhuptani Simple

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Chronic pancreatitis is a progressive, debilitating condition with no standardized treatment. Pirfenidone and simvastatin are potential therapeutic agents that exert anti-inflammatory and antifibrotic effects on pancreatic acinar cells.

AIM: To evaluate the synergistic effects of pirfenidone and simvastatin in an L-arginine-induced chronic pancreatitis model in mice.

METHODS

A preclinical, 7-week study was performed using a mouse model of L-arginine-induced chronic pancreatitis. The mice were divided into five groups: Normal control; model control; pirfenidone-treated; simvastatin-treated; and combination-treated (pirfenidone + simvastatin). Treatment started in week 3 after disease induction. Mice were euthanized at weeks 4 and 7 for blood collection and tissue sampling for histological and biomarker analysis, including cytokines, oxidative stress markers, and indicators of fibrosis.

RESULTS

Combination therapy significantly reduced levels of tumor necrosis factor-alpha (11.10 ± 1.57 pg/mL vs 24.30 ± 2.00 pg/mL), interleukin-10 (11.70 ± 1.12 pg/mL vs 19.60 ± 1.27 pg/mL), and transforming growth factor-beta 1 (236.13 ± 6.95 pg/mL vs 550.52 ± 42.18 pg/mL) at week 7 (P < 0.05 vs model control). The glutathione peroxidase 1 level increased across all treatment groups, significantly in the pirfenidone-treated group (5.47 ± 0.34 IU/mL vs 5.04 ± 0.43 IU/mL; P < 0.05). Lipid peroxidation levels decreased significantly in the combination-treated group (111.87 ± 7.36 mmol/mL vs 192.85 ± 0.98 mmol/mL; P < 0.05). Histology revealed extensive collagen accumulation and damage to the exocrine pancreas in the model control group (vs treatment groups). Combination therapy elicited the least damage.

CONCLUSION

Combination of pirfenidone and simvastatin demonstrated a synergistic therapeutic effect in reducing inflammation, fibrosis, and oxidative stress in an L-arginine-induced chronic pancreatitis mouse model, suggesting promise for chronic pancreatitis management.

Для цитирования: Mehta Rajiv, Patel Archi, Vyas Bhavin, Desai Bhargavi, Adhvaryu Dhvani, Sojitra Prakash, Bhuptani Simple. L-arginine-induced chronic pancreatitis in mice: Evaluating effects of pirfenidone and simvastatin.. World journal of gastrointestinal pharmacology and therapeutics. 2025. DOI: 10.4292/wjgpt.v16.i4.111977.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.